It is GSK’s global research funding programme designed to build a sustainable, long-term scientific research base.
Trust in Science
Trust in Science is GSK’s global research funding programme designed to build a sustainable, long-term scientific research base. It was started in Africa and Latin America to deliver medicines that are specific to patient needs.
Purpose
- drive sustainable investment in local scientific innovation and capabilities
- help translate science into meaningful benefits for patients
- deliver breakthrough science to address health issues for which there is currently no or little treatment
- support GSK’s position as healthcare partner of choice for scientists, and establish relationships leading to further collaborations share talent, technologies and scientific insight between GSK and selected research groups
In India, through the 'Trust in Science' (TiS) initiative, GSK has partnered with academic research institution Regional Centre of Biotechnology (RCB) which comes under the Department of Biotechnology, for fostering scientific and technological co-operation. The demand for well-trained and experienced biostatisticians and bio-informatics professionals vastly outweighs the supply. The role of these professionals in a data and AI-driven pharma research ecosystem is ever increasing. To address this gap, GSK collaborated with Regional Centre for Biotechnology to bring “Trust in Science” initiative in India in 2018.
What We Do
The objective of the Trust in Science program is to work in close collaboration with the Regional Centre of Biotechnology to initiate a full PhD program in Biostatistics and Bioinformatics to bridge the demand supply gap of well-trained and experienced statisticians.
How We Do It
GSK will collaborate with DBT in initiating full PhD programs in Biostatistics and Bioinformatics. DBT will be responsible for creating the program content, logistics and running the courses. GSK’s role will be to review course contents to ensure the program is shaped and targeted appropriately to better prepare students for progressing future careers in the Pharmaceutical industry.
In total, the Trust in Science program will support 12 PhD students for around seven years.
Outcomes
- Awareness and sensitization of the target audience (students and faculty members) about the Trust in Science program, thereby positively impacting recruitments to the program
- Capacity-building amongst the target audience to offer basics of the science (bioinformatics and biostatistics), the trends, and the future outlook from an industry perspective
- Engagement with though leaders in the bioinformatics/ biostatistics domain
Trust in Science Webinar series
A year after the launch of Trust in Science, GSK Pharma India and RCB organized the Trust in Science Webinar series with subject-matter & industry experts to reach out to prospective PhD students and faculty members.
The webinar series was launched with the following objectives:
 |
Awareness and sensitization
|
 |
Capacity-building
|
 |
Engagement with thought leaders
|
Panel of Experts for Trust in Science Webinars
| Speaker | Designation | Webinar Topic | |
|---|---|---|---|
 |
Dr. B. Jayaram | Professor Department of Chemistry & School of Biological Sciences, IIT Delhi | Bioinformatics and Biostatistics |
 |
Dr Sanghamitra Bandyopadhyay | JC Bose National Fellow, Professor Machine Intelligence Unit, Indian Statistical Institute, Calcutta |
Evolving Science with Data |
 |
Prof. Sayantan Banerjee | Professor, Operations Management & Quantitative Techniques, IIM Indore | Merging Science with Computing |
 |
Angshuman Sarkar | Head, Statistics and Biostatistics, GSK India | Quantitative Decision-Making in Clinical Development Plan |
 |
Dr. Andrew M. Lynn | Professor, School of Computational and Integrative Sciences, Jawaharlal Nehru University |
Looking Ahead! |
Engagement for Webinars
-
7M+
Impressions
-
900+
attendees
-
80+
institutions
